Proteomics

Dataset Information

Serum Protein Biomarkers for Early Diagnosis of Pancreatic Cancer


ABSTRACT: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers. Late presentation of disease at the time of diagnosis is one of the major reasons for dismal prognostic outcomes for PDAC patients. Currently, there is a lack of clinical biomarkers which can be used to diagnose PDAC patients at an early resectable stage. This study performed proteomic mass spectrometry to identify novel blood-based biomarkers for early diagnosis of PDAC.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Serum

DISEASE(S): Pancreatic Ductal Carcinoma

SUBMITTER: Sumit Sahni  

LAB HEAD: Sumit Sahni

PROVIDER: PXD046438 | Pride | 2024-03-05

REPOSITORIES: Pride